More recently, a study of 982 PD-L1 evaluable NSCLC patients showed that 14.3% had tumor cell membrane expression ≥50%, while another study of 1653 stage IV NSCLC patients, found that only 30.2% of patients met this cut-off [44,51]. Here, CD274 is linked to non-small cell lung carcinoma.